RETRACTED: Polysaccharide from Angelica sinensis ameliorates high-fat diet and STZ-induced hepatic oxidative stress and inflammation in diabetic mice by activating the Sirt1–AMPK pathway
Tài liệu tham khảo
Whiting, 2011, IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030, Diabetes Res Clin Pract, 94, 311, 10.1016/j.diabres.2011.10.029
Guariguata, 2014, Global estimates of diabetes prevalence for 2013 and projections for 2035, Diabetes Res Clin Pract, 103, 137, 10.1016/j.diabres.2013.11.002
Oggioni, 2014, Shifts in population dietary patterns and physical inactivity as determinants of global trends in the prevalence of diabetes: an ecological analysis, Nutr Metab Cardiovasc Dis, 24, 1105, 10.1016/j.numecd.2014.05.005
Saravanan, 2015, Role of thymol on hyperglycemia and hyperlipidemia in high fat diet-induced type 2 diabetic C57BL/6 J mice, Eur J Pharmacol, 761, 279, 10.1016/j.ejphar.2015.05.034
Subhasree, 2015, Antidiabetic and antihyperlipidemic activities of a novel polyherbal formulation in high fat diet/streptozotocin induced diabetic rat model, Indian J Pharmacol, 47, 509, 10.4103/0253-7613.165200
Skovso, 2014, Modeling type 2 diabetes in rats using high fat diet and streptozotocin, J Diabetes Investig, 5, 349, 10.1111/jdi.12235
Davidson, 2015, Effect of combination therapy consisting of enalapril, alpha-lipoic acid, and menhaden oil on diabetic neuropathy in a high fat/low dose streptozotocin treated rat, Eur J Pharmacol, 765, 258, 10.1016/j.ejphar.2015.08.015
Blachier, 2013, The burden of liver disease in Europe: a review of available epidemiological data, J Hepatol, 58, 593, 10.1016/j.jhep.2012.12.005
Caldwell, 1999, Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease, Hepatology, 29, 664, 10.1002/hep.510290347
Suman, 2016, Development of an experimental model of diabetes co-existing with metabolic syndrome in rats, Adv Pharmacol Sci, 2016, 9463476
Nagaishi, 2014, Mesenchymal stem cell therapy ameliorates diabetic hepatocyte damage in mice by inhibiting infiltration of bone marrow-derived cells, Hepatology, 59, 1816, 10.1002/hep.26975
Rolo, 2012, Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis, Free Radic Biol Med, 52, 59, 10.1016/j.freeradbiomed.2011.10.003
Chitturi, 2001, Etiopathogenesis of nonalcoholic steatohepatitis, Semin Liver Dis, 21, 27, 10.1055/s-2001-12927
Yu, 2013, Hepatitis C virus core protein induces hepatic metabolism disorders through down-regulation of the Sirt1–AMPK signaling pathway, Int J Infect Dis, 17, e539, 10.1016/j.ijid.2013.01.027
Gruzman, 2009, Adenosine monophosphate-activated protein kinase (AMPK) as a new target for antidiabetic drugs: a review on metabolic, pharmacological and chemical considerations, Rev Diabet Stud, 6, 13, 10.1900/RDS.2009.6.13
Hardie, 2007, AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy, Nat Rev Mol Cell Biol, 8, 774, 10.1038/nrm2249
Han, 2015, Korean Red Ginseng attenuates ethanol-induced steatosis and oxidative stress via AMPK/Sirt1 activation, J Ginseng Res, 39, 105, 10.1016/j.jgr.2014.09.001
Jung, 2015, BAIBA attenuates insulin resistance and inflammation induced by palmitate or a high fat diet via an AMPK–PPARdelta-dependent pathway in mice, Diabetologia, 58, 2096, 10.1007/s00125-015-3663-z
Salminen, 2011, AMP-activated protein kinase inhibits NF-kappaB signaling and inflammation: impact on healthspan and lifespan, J Mol Med, 89, 667, 10.1007/s00109-011-0748-0
Gao, 2015, Protective effect of polysaccharides from Opuntia dillenii Haw fruits on streptozotocin-induced diabetic rats, Carbohydr Polym, 124, 25, 10.1016/j.carbpol.2015.01.068
Zhou, 2015, Rehmannia glutinosa (Gaertn.) DC. Polysaccharide ameliorates hyperglycemia, hyperlipemia and vascular inflammation in streptozotocin-induced diabetic mice, J Ethnopharmacol, 164, 229, 10.1016/j.jep.2015.02.026
Zhou, 2015, Hypoglycemic activity and potential mechanism of a polysaccharide from the loach in streptozotocin-induced diabetic mice, Carbohydr Polym, 121, 199, 10.1016/j.carbpol.2014.12.037
Cao, 2010, A novel polysaccharide, isolated from Angelica sinensis (Oliv.) Diels induces the apoptosis of cervical cancer HeLa cells through an intrinsic apoptotic pathway, Phytomedicine, 17, 598, 10.1016/j.phymed.2009.12.014
Yu, 2013, Extraction optimization of Angelica sinensis polysaccharides and its antioxidant activity in vivo, Carbohydr Polym, 94, 114, 10.1016/j.carbpol.2013.01.050
Wang, 2016, Chronic administration of Angelica sinensis polysaccharide effectively improves fatty liver and glucose homeostasis in high-fat diet-fed mice, Sci Rep, 6, 26229, 10.1038/srep26229
Wang, 2016, Angelica sinensis polysaccharide attenuates concanavalin A-induced liver injury in mice, Int Immunopharmacol, 31, 140, 10.1016/j.intimp.2015.12.021
Zhang, 2014, The action of JAK, SMAD and ERK signal pathways on hepcidin suppression by polysaccharides from Angelica sinensis in rats with iron deficiency anemia, Food Funct, 5, 1381, 10.1039/c4fo00006d
McGrath, 2015, Transparency in research involving animals: the Basel Declaration and new principles for reporting research in BJP manuscripts, Br J Pharmacol, 172, 2427, 10.1111/bph.12956
Wang, 2015, Angelica sinensis polysaccharide regulates glucose and lipid metabolism disorder in prediabetic and streptozotocin-induced diabetic mice through the elevation of glycogen levels and reduction of inflammatory factors, Food Funct, 6, 902, 10.1039/C4FO00859F
Liang, 2014, Leucine modulates mitochondrial biogenesis and Sirt1–AMPK signaling in C2C12 myotubes, J Nutr Metab, 2014, 239750, 10.1155/2014/239750
Ford, 2005, Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival, Cancer Res, 65, 10457, 10.1158/0008-5472.CAN-05-1923
Guo, 2013, Renoprotective effect of ramulus mori polysaccharides on renal injury in STZ-diabetic mice, Int J Biol Macromol, 62, 720, 10.1016/j.ijbiomac.2013.09.022
He, 2011, NF-kappaB and STAT3 — key players in liver inflammation and cancer, Cell Res, 21, 159, 10.1038/cr.2010.183
Majumdar, 2013, Investigational anti-hyperglycemic agents: the future of type 2 diabetes therapy?, Endocrine, 44, 47, 10.1007/s12020-013-9884-3
Dong, 2014, Hepatoprotective effects of Yulangsan polysaccharide against isoniazid and rifampicin-induced liver injury in mice, J Ethnopharmacol, 152, 201, 10.1016/j.jep.2014.01.001
Xu, 1842, Stat3 signaling activation crosslinking of TGF-beta1 in hepatic stellate cell exacerbates liver injury and fibrosis, Biochim Biophys Acta, 2014, 2237
Pu, 2015, Polysaccharides from Angelica and Astragalus exert hepatoprotective effects against carbon-tetrachloride-induced intoxication in mice, Can J Physiol Pharmacol, 93, 39, 10.1139/cjpp-2014-0331
Liu, 2015, Hepatoprotective effects of polysaccharides extracted from Zizyphus jujube cv. Huanghetanzao, Int J Biol Macromol, 76, 169, 10.1016/j.ijbiomac.2015.01.061
Choi, 2013, Involvement of Sirt1–AMPK signaling in the protective action of indole-3-carbinol against hepatic steatosis in mice fed a high-fat diet, J Nutr Biochem, 24, 1393, 10.1016/j.jnutbio.2012.11.007
Kahn, 2006, Mechanisms linking obesity to insulin resistance and type 2 diabetes, Nature, 444, 840, 10.1038/nature05482
Ren, 2012, Cordycepin suppresses TNF-alpha-induced NF-kappaB activation by reducing p65 transcriptional activity, inhibiting IkappaBalpha phosphorylation, and blocking IKKgamma ubiquitination, Int Immunopharmacol, 14, 698, 10.1016/j.intimp.2012.10.008
Song, 2013, Sophocarpine alleviates hepatocyte steatosis through activating AMPK signaling pathway, Toxicol In Vitro, 27, 1065, 10.1016/j.tiv.2013.01.020
Caldwell, 2004, Mitochondria in nonalcoholic fatty liver disease, Clin Liver Dis, 8, 595, 10.1016/j.cld.2004.04.009
Yamauchi, 2002, Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase, Nat Med, 8, 1288, 10.1038/nm788
Purushotham, 2009, Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation, Cell Metab, 9, 327, 10.1016/j.cmet.2009.02.006
Yang, 2010, Macrophage alpha1 AMP-activated protein kinase (alpha1AMPK) antagonizes fatty acid-induced inflammation through SIRT1, J Biol Chem, 285, 19051, 10.1074/jbc.M110.123620